Farrokh Dehdashti, M.D.
Washington University School of Medicine · Washington Univesity in St. Louis
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Farrokh Dehdashti, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:27 UTC. Open this list on ClinicalTrials.gov
- Early Ph1NCT06636175 · 64Cu-LLP2A for Imaging Hematologic MalignanciesWashington University School of Medicine · terminated · Multiple Myeloma, Low-Grade Lymphoma, Follicular Lymphoma · principal investigator
- Early Ph1NCT05048732 · Imaging Apoptosis for Lymphoma Treatment ResponseWashington University School of Medicine · terminated · Diffuse Large B Cell Lymphoma · principal investigator
- Ph1NCT04217057 · Imaging CCR2 Receptors With 64Cu-DOTA-ECL1i in Head and Neck CancerWashington University School of Medicine · terminated · Head and Neck Cancer · principal investigator
- Ph1NCT03851237 · CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted TherapyWashington University School of Medicine · completed · Pancreatic Ductal Adenocarcinoma · principal investigator
- Early Ph1NCT03804424 · 64Cu-LLP2A for Imaging Multiple MyelomaWashington University School of Medicine · terminated · Multiple Myeloma · principal investigator
- Ph2NCT02455453 · Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission TomographyWashington University School of Medicine · completed · Breast Cancer · principal investigator
- N/ANCT01714128 · FES-PET for Patients Treated on NCI Protocol 8762Washington University School of Medicine · withdrawn · Breast Cancer · principal investigator
- Ph1NCT00968409 · Assessment of Progesterone Receptors in Breast Carcinoma by Positron Emission Tomography (PET) Using Fluoro Furanyl Norprogesterone (FFNP)Washington University School of Medicine · completed · Breast Cancer · principal investigator
- Ph1NCT00968656 · Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1Washington University School of Medicine · completed · Breast Cancer, Head and Neck Cancer, Diffuse Large B-cell Lymphoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Development and Commercialization of a New Molecularly Targeted Imaging Agent for Multiple MyelomaR42CA257797 · NCI · SARYA, LLC · PI Mikhail Y. Berezin · fiscal years 2021 to 2024Named on NCT06636175
- The PET Radiotracer Translation and Resource Center (PET-RTRC) Training & DisseminationP41EB025815 · NIBIB · WASHINGTON UNIVERSITY · PI Buck E. Rogers · fiscal years 2018 to 2026Named on NCT04217057
- Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted TherapyR01CA235672 · NCI · WASHINGTON UNIVERSITY · PI FARROKH DEHDASHTI, Kian-Huat Lim, Yongjian Liu · fiscal years 2019 to 2024Named on NCT03851237
- ASSESSMENT OF FUNCTIONAL STATUS OF ESTROGEN RECEPTORS IN BREAST CANCER BY PETR01CA195450 · NCI · WASHINGTON UNIVERSITY · PI FARROKH DEHDASHTI · fiscal years 2015 to 2017Named on NCT02455453
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.